Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tonix Pharma ( (TNXP) ) just unveiled an announcement.
Tonix Pharmaceuticals has submitted a New Drug Application to the FDA for its TNX-102 SL product aimed at treating fibromyalgia, backed by promising data from two controlled studies. This move highlights Tonix’s strategic focus on expanding its market footprint with innovative treatments, although the outcome remains subject to regulatory review and market dynamics.
Learn more about TNXP stock on TipRanks’ Stock Analysis page.